Market Overview

ISI Group Downgrades Bruker To Neutral

Share:
Related BRKR
Deutsche Bank Optimistic On Fundamentals In Life Science Tools/Diagnostics Sector
Pressure Biosciences CEO On Its Beaten Down Stock: 'We Can Now Begin To Focus On The Area That Is Most Important'

Analysts at ISI Group downgraded Bruker (NASDAQ: BRKR) from “buy” to “neutral.”

Bruker shares have surged 44.61% over the past 52 weeks, while the S&P 500 index has gained 19.69% in the same period.

Bruker's shares fell 2.20% to close at $24.02 yesterday.

Latest Ratings for BRKR

DateFirmActionFromTo
Jan 2017Deutsche BankInitiates Coverage OnHold
Jan 2017BarclaysDowngradesOverweightEqual-Weight
Dec 2016JP MorganDowngradesNeutralUnderweight

View More Analyst Ratings for BRKR
View the Latest Analyst Ratings

Posted-In: ISI GroupDowngrades Analyst Ratings

 

Related Articles (BRKR)

View Comments and Join the Discussion!